These constraints in the BTNX NTS are hugely related, as we identified e.g. etodesnitazene to own the same in vitro potency and efficacy as fentanyl [7, 13] and as it may perhaps give PWUD a Bogus sense of basic safety. In addition, the detectability of nitazene analogues in drug samples can be impacted by solubility troubles, as highlighted by the